European Diagnostic Reimbursement & Market Access Conference

Recognizing the Nuances of Securing Funding for Diagnostic Tests in Europe through Collaboration with Member States, Utilization of HTA’s and Enhanced Exhibition of Clinical Utility

September 20-21, 2010
Frankfurt, Germany

About the Conference

As diagnostic tests continue to evolve in their complexity and abundance, manufacturers face great challenges in finding support for these tests in an increasingly crowded marketplace. With manufacturers continuing to innovate and create cutting edge diagnostic products, healthcare payers and physicians are equally challenged to determine which test is the most effective for their patient populations. Entering into the European market has long been a challenge for diagnostic manufacturers, where diverse processes and procedures for consideration and sale are constantly evolving, and where cost-containment is often a top priority. This conference program will provide critical information for organizations looking to secure a top-rate of reimbursement for their new and existing diagnostic tests throughout the European market.

Key Presenters to Include

Rainer Voelksen
Executive, Quality Regulatory Medical
GE Healthcare EMEA

José Manuel Rodriguez
Regional Health Economics & Reimbursement Director
Ortho Clinical Diagnostics

Geraldine Roeder
Northern European Market Development, Women's Health
QIAGEN GmbH

And Many More...

Topics to Include

• The Future of IVD Testing and Reimbursement Processes in Europe
  
• Designing Clinical Studies to Support Diagnostic Product Reimbursement
  
• Understanding the Role of Clinical Utility in Reimbursement from a Private Payer Perspective
  
• Using a Risk Adjusted Reimbursement Strategy for Accurate National Healthcare System Budgeting
  
• Value Based Pricing: Achieving True Market Value
  
• Understanding Changes to the Medical Device Directives for Diagnostics
  
• Changes in CE Marking Requirement for IVDs
  
• Maximizing the Value in Conducting and Communicating Evidence from HTAs
  
• Changes to NICE Procedures for Reviewing Diagnostics
  
• Combining Resources to Ensure Fair Pricing and On-Time Reimbursement for Smaller Diagnostic Companies
  
• Implementing Reimbursement Strategies During Product Development to Ensure VC Funding
  
• Successful Reimbursement of Companion Diagnostics
  
• Securing Reimbursement and Recognizing Financial Benefits of Point-of-Care-Testing
  
• Evaluating Health Trends as Guide for Developing Reimbursable Diagnostics for Potential Epidemics
  
• Successful Diagnostic Reimbursement Pathways for Germany
  
• Obtaining Diagnostic Reimbursement in Various EU Countries (UK, France, Italy, Spain, Netherlands)
  
• Navigating the Reimbursement Landscape for Diagnostics in Eastern European Countries
  
• Achieving Reimbursement for Diagnostics in the US
  
• Obtaining Diagnostic Reimbursement in China
  
• Legal Implications and Compliance Concerns in Promoting Coverage & Reimbursement

To request the full two-day conference agenda, information on promotional pricing & registration details please contact:
Paul Hernandez, Marketing Manager
phernandez@Q1productions.com
312-602-9683